Human cardiac tissue engineering: From pluripotent stem cells to heart repair

Current Opinion in Chemical Engineering

Volumn 7, Issue , 2015, Pages 57-64

  Jackman, Christopher P ^a   Shadrin, Ilya Y ^a   Carlson, Aaron L ^a   Bursac, Nenad ^a  

^a Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; CYTOLOGY; DIAGNOSIS; HEART; HISTOLOGY; REPAIR; STEM CELLS; TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; CELL BASED THERAPIES; FUNCTIONAL TISSUE ENGINEERINGS; HUMAN PHYSIOLOGY; PLURIPOTENT STEM CELLS; RECENT PROGRESS; TOXICOLOGY SCREENING;

TISSUE;

EID: 84916917517     PISSN: None     EISSN: 22113398     Source Type: Journal    
DOI: 10.1016/j.coche.2014.11.004     Document Type: Review

References (63)

1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A: Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010, 35:72-115.
2. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ: Cell therapy for cardiac repair-lessons from clinical trials. Nat Rev Cardiol 2014, 11:232-246.
3. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ: Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009, 104 :e30-e41.
4. Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ: Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview . Circ Res 2012, 111:344-358.
5. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G: Stage-specific optimization of activin/ nodal and bmp signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8:228-240.
6. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP: Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating wnt/bcatenin signaling under fully defined conditions. Nat Protoc 2013, 8:162-175.
7. Zhang J, Klos M, Wilson GF, Herman AM, Lian X, Raval KK, Barron MR, Hou L, Soerens AG, Yu J, Palecek SP et al.: Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 2012, 111:1125-1136.
8. Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, Plews JR et al.: Chemically defined generation of human cardiomyocytes. Nat Methods 2014, 11:855-860.
9. Skelton RJP, Costa M, Anderson DJ, Bruveris F, Finnin BW, Koutsis K, Arasaratnam D, White AJ, Rafii A, Ng ES, Elefanty AG et al.: SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res 2014, 13:172-179.
10. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh Y-s, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K et al.: Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 2010, 7:61-66.
11. Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, Hashimoto H, Suzuki T, Yamashita H, Satoh Y, Egashira T et al.: Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013, 12:127-137.
12. Ben-David U, Gan Q-F, Golan-Lev T, Arora P, Yanuka O, Oren Yifat S, Leikin-Frenkel A, Graf M, Garippa R, Boehringer M, Gromo G et al.: Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a highthroughput screen . Cell Stem Cell 2013, 12:167-179.
13. Liau B, Christoforou N, Leong KW, Bursac N: Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011, 32:9180-9187.
14. Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R, Schwanke K, Hegermann J, Skvorc D, Gawol A, Azizian A, Wagner S, Maier LS et al.: Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J 2013, 34:1134-1146.
15. Thavandiran N, Dubois N, Mikryukov A, Massé S, Beca B, Simmons CA, Deshpande VS, McGarry JP, Chen CS, Nanthakumar K, Keller GM et al.: Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A 2013, 110:E4698-E4707.
16. Yang X, Pabon L, Murry CE: Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014, 114 :511-523.
17. van den Heuvel NH, van Veen TA, Lim B, Jonsson MK: Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes . J Mol Cell Cardiol 2014, 67:12-25.
18. Lundy SD, Zhu W-Z, Regnier M, Laflamme MA: Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 2013, 22:1991-2002.
19. Vreeker A, van Stuijvenberg L, Hund TJ, Mohler PJ, Nikkels PGJ, van Veen TAB: Assembly of the cardiac intercalated disk during pre- and postnatal development of the human heart. PLOS ONE 2014, 9:e94722.
20. Yang X, Rodriguez M, Pabon L, Fischer KA, Reinecke H, Regnier M, Sniadecki NJ, Ruohola-Baker H, Murry CE: Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 2014, 72:296-304.
21. Naqvi N, Li M, Calvert John W, Tejada T, Lambert Jonathan P, Wu J, Kesteven Scott H, Holman Sara R, Matsuda T, Lovelock Joshua D, Howard Wesley W et al.: A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 2014, 157:795-807.
22. Chattergoon NN, Giraud GD, Louey S, Stork P, Fowden AL, Thornburg KL: Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J 2012, 26:397-408.
23. Zhang D, Shadrin IY, Lam J, Xian H-Q, Snodgrass HR, Bursac N: Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
24. Bian W, Badie N, Himel Iv HD, Bursac N: Robust t-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics . Biomaterials 2014, 35:3819-3828.
25. Ibrahim M, Terracciano CM: Reversibility of t-tubule remodelling in heart failure: mechanical load as a dynamic regulator of the t-tubules. Cardiovasc Res 2013, 98:225-232.
26. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T, Kawamura T, Kuratani T, Daimon T, Shimizu T, Okano T et al.: Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126(Suppl. 1):S29-S37.
27. Hirt MN, Boeddinghaus J, Mitchell A, Schaaf S, Börnchen C, Müller C, Schulz H, Hubner N, Stenzig J, Stoehr A, Neuber C et al.: Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 2014, 74:151-161.
28. Schaaf S, Shibamiya A, Mewe M, Eder A, Stöhr A, Hirt MN, Rau T, Zimmermann W-H, Conradi L, Eschenhagen T, Hansen A: Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS ONE 2011, 6:e26397.
29. Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B, Jiang J, Masse S, Gagliardi M, Hsieh A, Thavandiran N et al.: Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes . Nat Methods 2013, 10:781-787.
30. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE: Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011, 109:47-59.
31. Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee JJ, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, Hajjar RJ et al.: Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium . FASEB J 2014, 28 :644-654.
32. Mihic A, Li J, Miyagi Y, Gagliardi M, Li S-H, Zu J, Weisel RD, Keller G, Li R-K: The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 2014, 35:2798-2808.
33. Matsa E, Burridge PW, Wu JC: Human stem cells for modeling heart disease and for drug discovery. Sci Transl Med 2014, 6:239ps236.
34. Stoehr A, Neuber C, Baldauf C, Vollert I, Friedrich FW, Flenner F, Carrier L, Eder A, Schaaf S, Hirt MN, Aksehirlioglu B et al.: Automated analysis of contractile force and Ca2+ transients in engineered heart tissue . Am J Physiol Heart Circ Physiol 2014, 306:H1353-H1363.
35. Clements M, Thomas N: High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multielectrode arrays. Toxicol Sci 2014, 140:445-461.
36. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, Higuchi T, Shimizu T, Okano T, Yamanaka S, Sawa Y: Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med 2012, 1:430-437.
37. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, Nguyen K, Rouy D, Altman P, Schwarz R, Mendizabal A, Oskouei B et al.: Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011, 161:487-493.
38. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LEJ, Berman D, Czer LSC, Marbán L, Mendizabal A, Johnston PV, Russell SD et al.: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): a prospective, randomised phase 1 trial . Lancet 2012, 379: 895-904.
39. Malliaras K, Kreke M, Marban E: The stuttering progress of cell therapy for heart disease . Clin Pharmacol Ther 2011, 90: 532-541.
40. Roche ET, Hastings CL, Lewin SA, Shvartsman DE, Brudno Y, Vasilyev NV, O'Brien FJ, Walsh CJ, Duffy GP, Mooney DJ: Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 2014, 35:6850-6858.
41. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
42. Projahn D, Simsekyilmaz S, Singh S, Kanzler I, Kramp BK, Langer M, Burlacu A, Bernhagen J, Klee D, Zernecke A, Hackeng TM et al.: Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction. J Cell Mol Med 2014, 18:790-800.
43. Shiba Y, Filice D, Fernandes S, Minami E, Dupras SK, Biber BV, Trinh P, Hirota Y, Gold JD, Viswanathan M, Laflamme MA: Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model. J Cardiovasc Pharmacol Ther 2014, 19:368-381.
44. Chong JJH, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H et al.: Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014.
45. Anderson ME, Goldhaber JI, Houser SR, Puceat M, Sussman MA: Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ Res 2014, 115:335-338.
46. Angst BD, Khan LUR, Severs NJ, Whitely K, Rothery S, Thompson RP, Magee AI, Gourdie RG: Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ Res 1997, 80:88-94.
47. 2+ sparks in rat cardiomyocytes . Cardiovasc Res 2003, 58:535-548.
48. Laflamme MA, Murry CE: Heart regeneration. Nature 2011, 473:326-335.
49. Oparil S: Pathogenesis of ventricular hypertrophy. J Am Coll Cardiol 1985, 5(Suppl. 1) :57B-65B.
50. Sekine H, Shimizu T, Dobashi I, Matsuura K, Hagiwara N, Takahashi M, Kobayashi E, Yamato M, Okano T: Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 2011, 17:2973-2980.
51. Coulombe KL, Bajpai VK, Andreadis ST, Murry CE: Heart regeneration with engineered myocardial tissue. Annu Rev Biomed Eng 2014, 16:1-28.
52. Keung W, Boheler K, Li R: Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 2014, 5 :1-11.
53. Lu TY, Lin B, Kim J, Sullivan M, Tobita K, Salama G, Yang L: Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells . Nat Commun 2013, 4.
54. Durrer D, van Dam RT, Freud GE, Janse MJ, Meijler FL, Arzbaecher RC: Total excitation of the isolated human heart. Circulation 1970, 41 :899-912.
55. Glukhov AV, Fedorov VV, Lou Q, Ravikumar VK, Kalish PW, Schuessler RB, Moazami N, Efimov IR: Transmural dispersion of repolarization in failing and nonfailing human ventricle . Circ Res 2010, 106 :981-991.
56. Koller ML, Maier SK, Gelzer AR, Bauer WR, Meesmann M, Gilmour RF Jr: Altered dynamics of action potential restitution and alternans in humans with structural heart disease . Circulation 2005, 112 :1542-1548.
57. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR: Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
58. Hasenfuss G, Mulieri L, Blanchard E, Holubarsch C, Leavitt B, Ittleman F, Alpert N: Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. Circ Res 1991, 68:836-846.
59. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L: Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007, 50:1884-1893.
60. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, den Ouden K, Ward-van Oostwaard D, Korving J, Tertoolen LG, van Echteld CJ et al.: Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007, 1:9-24.
61. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE: Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol 2010, 49:941-949.
62. Shiba Y, Fernandes S, Zhu W-Z, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B et al.: Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489:322-325.
63. Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC: Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells . J Am Coll Cardiol 2014, 64:436-448.